CaMKIIδ gene editing - A base hit for the heart

Keywords

Base editing / heart / ischemia-reperfusion / aav / crispr

References

[1] Lebek S,Caravia XM.Ablation of CaMKIIδ oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease.Science2023;379:179-85

[2] Hausenloy DJ.Myocardial ischemia-reperfusion injury: a neglected therapeutic target.J Clin Invest2013;123:92-100 PMCID:PMC3533275

[3] He BJ,Singh MV.Oxidation of CaMKII determines the cardiotoxic effects of aldosterone.Nat Med2011;17:1610-8 PMCID:PMC3332099

[4] Zhang R,Wu Y.Calmodulin kinase II inhibition protects against structural heart disease.Nat Med2005;11:409-17

[5] van Oort RJ,Dixit SS.Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure.Circulation2010;122:2669-79 PMCID:PMC3075419

[6] Zhang T,Dalton ND.The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.Circ Res2003;92:912-9

[7] Purohit A,Guan X.Oxidized Ca²⁺/calmodulin-dependent protein kinase II triggers atrial fibrillation.Circulation2013;128:1748-57 PMCID:PMC3876034

[8] Erickson JR,Guan X.A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation.Cell2008;133:462-74 PMCID:PMC2435269

[9] Gaudelli NM,Rees HA.Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.Nature2017;551:464-71

[10] Anzalone AV,Liu DR.Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.Nat Biotechnol2020;38:824-44

[11] Hakim CH,Pérez-López DO.Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models.Nat Commun2021;12:6769 PMCID:PMC8613397